Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and tolerability of an adeno-associated
virus vector expressing CYP4V2 in patients with Bietti's crystalline dystrophy (BCD).